Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease

Journal of Nutritional Biochemistry

Volumn 22, Issue 1, 2011, Pages 38-45

  Kirpich, Irina A ^a   Gobejishvili, Leila N ^a   Homme, Marjorie Bon ^a   Waigel, Sabine ^b   Cave, Matt ^a,c   Arteel, Gavin ^a   Barve, Shirish S ^a   McClain, Craig J ^a,c   Deaciuc, Ion V ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

High fat diet; Liver gene expression; Liver proteomic analysis; Nonalcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; FATTY ACID; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; PROTEOME; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 2; TRANSCRIPTOME; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; INFLAMMATION; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TRIACYLGLYCEROL BLOOD LEVEL; XENOBIOTIC METABOLISM;

ANIMALS; DIETARY FATS; FATTY ACIDS; FATTY LIVER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; RNA, MESSENGER; SELENIUM-BINDING PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

MUS;

EID: 78649963675     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.11.009     Document Type: Article

References (60)

1. Marrero J.A., Fontana R.J., Su G.L., Conjeevaram H.S., Emick D.M., Lok A.S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36:1349-1354.
2. Bullock R.E., Zaitoun A.M., Aithal G.P., Ryder S.D., Beckingham I.J., Lobo D.N. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. J Hepatol 2004, 41:685-686.
3. Marchesini G., Brizi M., Morselli-Labate A.M., Bianchi G., Bugianesi E., McCullough A.J., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999, 107:450-455.
4. Yeh M.M., Brunt E.M. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 2007, 128:837-847.
5. Clark J.M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006, 40(Suppl 1):S5-S10.
6. Day C.P., James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845.
7. McClain C.J., Mokshagundam S.P., Barve S.S., Song Z., Hill D.B., Chen T., et al. Mechanisms of non-alcoholic steatohepatitis. Alcohol 2004, 34:67-79.
8. Tilg H., Hotamisligil G.S. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006, 131:934-945.
9. Baranova A., Liotta L., Petricoin E., Younossi Z.M. The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease. Clin Liver Dis 2007, 11:209-220. xi.
10. Rubio A., Guruceaga E., Vazquez-Chantada M., Sandoval J., Martinez-Cruz L.A., Segura V., et al. Identification of a gene-pathway associated with non-alcoholic steatohepatitis. J Hepatol 2007, 46:708-718.
11. Sharma M.R., Polavarapu R., Roseman D., Patel V., Eaton E., Kishor P.B., et al. Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis. Exp Mol Pathol 2006, 81:202-210.
12. Toye A.A., Dumas M.E., Blancher C., Rothwell A.R., Fearnside J.F., Wilder S.P., et al. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia 2007, 50:1867-1879.
13. Yoneda M., Endo H., Mawatari H., Nozaki Y., Fujita K., Akiyama T., et al. Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis. Hepatol Res 2008, 38:1204-1212.
14. Younossi Z.M., Gorreta F., Ong J.P., Schlauch K., Del Giacco L., Elariny H., et al. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int 2005, 25:760-771.
15. Meneses-Lorente G., Watt A., Salim K., Gaskell S.J., Muniappa N., Lawrence J., et al. Identification of early proteomic markers for hepatic steatosis. Chem Res Toxicol 2006, 19:986-998.
16. Spano D., Cimmino F., Capasso M., D'Angelo F., Zambrano N., Terracciano L., et al. Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis. J Proteome Res 2008, 7:2642-2653.
17. Orimo T., Ojima H., Hiraoka N., Saito S., Kosuge T., Kakisaka T., et al. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology 2008, 48:1851-1863.
18. Santamaria E., Munoz J., Fernandez-Irigoyen J., Prieto J., Corrales F.J. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics. Liver Int 2007, 27:163-173.
19. Chanson A., Sayd T., Rock E., Chambon C., Sante-Lhoutellier V., Potier de Courcy G., et al. Proteomic analysis reveals changes in the liver protein pattern of rats exposed to dietary folate deficiency. J Nutr 2005, 135:2524-2529.
20. Zhang L., Perdomo G., Kim D.H., Qu S., Ringquist S., Trucco M., et al. Proteomic analysis of fructose-induced fatty liver in hamsters. Metabolism 2008, 57:1115-1124.
21. Morand J.P., Macri J., Adeli K. Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia. J Biol Chem 2005, 280:17626-17633.
22. Schmid G.M., Converset V., Walter N., Sennitt M.V., Leung K.Y., Byers H., et al. Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics 2004, 4:2270-2282.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
24. Tshala-Katumbay D., Monterroso V., Kayton R., Lasarev M., Sabri M., Spencer P. Probing mechanisms of axonopathy: Part I. Protein targets of 1,2-diacetylbenzene, the neurotoxic metabolite of aromatic solvent 1,2-diethylbenzene. Toxicol Sci 2008, 105:134-141.
25. Hoffler U., Hobbie K., Wilson R., Bai R., Rahman A., Malarkey D., et al. Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice. Endocrine 2009, 36:311-325.
26. Kim S., Sohn I., Ahn J.I., Lee K.H., Lee Y.S., Lee Y.S. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004, 340:99-109.
27. Kreeft A.J., Moen C.J., Porter G., Kasanmoentalib S., Sverdlov R., van Gorp P.J., et al. Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regulation of lipid and inflammatory genes. Atherosclerosis 2005, 182:249-257.
28. Gregoire F.M., Zhang Q., Smith S.J., Tong C., Ross D., Lopez H., et al. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am J Physiol Endocrinol Metab 2002, 282:E703-713.
29. Kim S., Sohn I., Lee Y.S., Lee Y.S. Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr 2005, 135:33-41.
30. Sanyal A.J., Campbell-Sargent C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120:1183-1192.
31. Younossi Z.M., Baranova A., Ziegler K., Del Giacco L., Schlauch K., Born T.L., et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology 2005, 42:665-674.
32. Aleksunes L.M., Manautou J.E. Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol Pathol 2007, 35:459-473.
33. Formigari A., Irato P., Santon A. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C Toxicol Pharmacol 2007, 146:443-459.
34. Pitari G., Malergue F., Martin F., Philippe J.M., Massucci M.T., Chabret C., et al. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of vanin-1 deficient mice. FEBS Lett 2000, 483:149-154.
35. Martinez-Chantar M.L., Garcia-Trevijano E.R., Latasa M.U., Perez-Mato I., Sanchez del Pino M.M., Corrales F.J., et al. Importance of a deficiency in S-adenosyl-l-methionine synthesis in the pathogenesis of liver injury. Am J Clin Nutr 2002, 76:1177S-1182S.
36. Avila M.A., Carretero M.V., Rodriguez E.N., Mato J.M. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology 1998, 114:364-371.
37. Mato J.M., Alvarez L., Ortiz P., Pajares M.A. S-Adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther 1997, 73:265-280.
38. Chen L., Zeng Y., Yang H., Lee T.D., French S.W., Corrales F.J., et al. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. Faseb J 2004, 18:914-916.
39. Lu S.C., Alvarez L., Huang Z.Z., Chen L., An W., Corrales F.J., et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A 2001, 98:5560-5565.
40. Santamaria E., Munoz J., Fernandez-Irigoyen J., Sesma L., Mora M.I., Berasain C., et al. Molecular profiling of hepatocellular carcinoma in mice with a chronic deficiency of hepatic S-adenosylmethionine: relevance in human liver diseases. J Proteome Res 2006, 5:944-953.
41. Zannis V.I., Kypreos K.E., Chroni A., Kardassi D., Zanni E.E. Lipoproteins and atherogenesis. Molecular mechanisms of atherosclerosis 2004, 111-174. Taylor & Francis, New York, NY. J. Loscalzo (Ed.).
42. Kuipers F., Jong M.C., Lin Y., Eck M., Havinga R., Bloks V., et al. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J Clin Invest 1997, 100:2915-2922.
43. Karagiannides I., Abdou R., Tzortzopoulou A., Voshol P.J., Kypreos K.E. Apolipoprotein E redisposes to obesity and related metabolic dysfunctions in mice. Febs J 2008, 275:4796-4809.
44. Mattow J., Demuth I., Haeselbarth G., Jungblut P.R., Klose J. Selenium-binding protein 2, the major hepatic target for acetaminophen, shows sex differences in protein abundance. Electrophoresis 2006, 27:1683-1691.
45. Bansal M.P., Mukhopadhyay T., Scott J., Cook R.G., Mukhopadhyay R., Medina D. DNA sequencing of a mouse liver protein that binds selenium: implications for selenium's mechanism of action in cancer prevention. Carcinogenesis 1990, 11:2071-2073.
46. Henkel C., Roderfeld M., Weiskirchen R., Scheibe B., Matern S., Roeb E. Identification of fibrosis-relevant proteins using DIGE (difference in gel electrophoresis) in different models of hepatic fibrosis. Z Gastroenterol 2005, 43:23-29.
47. Park J.Y., Seong J.K., Paik Y.K. Proteomic analysis of diet-induced hypercholesterolemic mice. Proteomics 2004, 4:514-523.
48. Santamaria E., Avila M.A., Latasa M.U., Rubio A., Martin-Duce A., Lu S.C., et al. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci U S A 2003, 100:3065-3070.
49. Lewis S.A., Tian G., Vainberg I.E., Cowan N.J. Chaperonin-mediated folding of actin and tubulin. J Cell Biol 1996, 132:1-4.
50. Barrett A.J., Rawlings N.D., Davies M.E., Machleidt W., Salvesen G., Turk V. Proteinase inhibitors. Research monographs in cell and tissue physiology 1986, 12:515-569. Elsevier, Amsterdam. A.J. Barrett, G. Salvesen (Eds.).
51. Strojan P., Oblak I., Svetic B., Smid L., Kos J. Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis. Br J Cancer 2004, 90:1961-1968.
52. Piwowar A., Fus I., Kanapik-Kordecka M., Warwas M. Serum stefin A in patients with type 2 diabetes. Pol Arch Med Wewn 2004, 111:319-325.
53. Timm D.E., Baker L.J., Mueller H., Zidek L., Novotny M.V. Structural basis of pheromone binding to mouse major urinary protein (MUP-I). Protein Sci 2001, 10:997-1004.
54. Edvardsson U., von Lowenhielm H.B., Panfilov O., Nystrom A.C., Nilsson F., Dahllof B. Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators. Proteomics 2003, 3:468-478.
55. Harford J.B., Morris D.R. Post-transcriptional gene regulation 1997, Wiley-Liss, Inc., New York (NY).
56. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci U S A 1996, 93:12142-12149.
57. Urlinger S., Kuchler K., Meyer T.H., Uebel S., Tampe R. Intracellular location, complex formation, and function of the transporter associated with antigen processing in yeast. Eur J Biochem 1997, 245:266-272.
58. Shackel N.A., Seth D., Haber P.S., Gorrell M.D., McCaughan G.W. The hepatic transcriptome in human liver disease. Comp Hepatol 2006, 5:6.
59. Griffin T.J.G.S., Ideker T., Rist B., Eng J., Hood L., Aebersold R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 2002, 1:323-333.
60. Kislinger T., Cox B., Kannan A., Chung C., Hu P., Ignatchenko A., et al. Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006, 125:173-186.